186 related articles for article (PubMed ID: 28145609)
1. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
Kalkman DN; Woudstra P; Lu H; Menown IBA; den Heijer P; Suryapranata H; Iñiguez A; Arkenbout KE; Van't Hof AWJ; Muller P; Erglis A; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):E31-E37. PubMed ID: 28145609
[TBL] [Abstract][Full Text] [Related]
2. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
[TBL] [Abstract][Full Text] [Related]
3. Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
Kalkman DN; Kerkmeijer LS; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2019 Sep; 94(3):342-347. PubMed ID: 30565371
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
de Winter RJ; Chandrasekhar J; Kalkman DN; Aquino MB; Woudstra P; Beijk MA; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; ;
JACC Cardiovasc Interv; 2018 Oct; 11(19):1969-1978. PubMed ID: 30286855
[TBL] [Abstract][Full Text] [Related]
5. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
Chandrasekhar J; de Winter VC; Kalkman DN; Sartori S; Chandiramani R; Aquino MB; de Wilde P; Zeebregts D; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Coufal Z; Lee M; Tijssen JG; Koch KT; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Cardiovasc Drugs Ther; 2021 Apr; 35(2):309-320. PubMed ID: 33515411
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
[TBL] [Abstract][Full Text] [Related]
7. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
8. Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent.
Kalkman DN; Woudstra P; Menown IBA; Tijssen JG; Beijk MAM; de Winter RJ;
Cardiovasc Revasc Med; 2018; 19(3 Pt B):373-375. PubMed ID: 29277288
[TBL] [Abstract][Full Text] [Related]
9. The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.
de la Torre Hernandez JM; Moreno R; Gonzalo N; Rivera R; Linares JA; Veiga Fernandez G; Gomez Menchero A; Garcia Del Blanco B; Hernandez F; Benito Gonzalez T; Subinas A; Escaned J
Cardiovasc Revasc Med; 2019 Aug; 20(8):705-710. PubMed ID: 30414798
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry.
Kerkmeijer LS; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; Van't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Cardiovasc Revasc Med; 2020 May; 21(5):567-570. PubMed ID: 31662276
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the planned one- and elective two-stent techniques in patients with coronary bifurcation lesions with or without acute coronary syndrome from the COBIS II Registry.
Kim MC; Ahn Y; Sun Sim D; Joon Hong Y; Han Kim J; Ho Jeong M; Gwon HC; Kim HS; Rha SW; Yoon JH; Jang Y; Tahk SJ; Seung KB
Catheter Cardiovasc Interv; 2018 Nov; 92(6):1050-1060. PubMed ID: 29573537
[TBL] [Abstract][Full Text] [Related]
12. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
13. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
Haude M; Lee SW; Worthley SG; Silber S; Verheye S; Erbs S; Rosli MA; Botelho R; Meredith I; Sim KH; Stella PR; Tan HC; Whitbourn R; Thambar S; Abizaid A; Koh TH; Den Heijer P; Parise H; Cristea E; Maehara A; Mehran R
JACC Cardiovasc Interv; 2013 Apr; 6(4):334-43. PubMed ID: 23523459
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice: 2-Year Results of the ISAR-ABSORB Registry.
Wiebe J; Hoppmann P; Colleran R; Kufner S; Valeskini M; Cassese S; Schneider S; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
JACC Cardiovasc Interv; 2017 Jun; 10(12):1222-1229. PubMed ID: 28641842
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
[TBL] [Abstract][Full Text] [Related]
16. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Buszman PP; Orlik B; Trela B; Milewski K; Kozlowski M; Pruski M; Drzewiecki J; Peppas A; Granada JF; Kaluza GL; Buszman PE
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E155-62. PubMed ID: 23109067
[TBL] [Abstract][Full Text] [Related]
17. Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Kerkmeijer LSM; Chandrasekhar J; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2021 Sep; 98(3):503-510. PubMed ID: 33029937
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry).
Dvir D; Barbash IM; Torguson R; Badr S; Sardi GL; Laynez-Carnicero A; Ben-Dor I; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2013; 14(3):128-33. PubMed ID: 23642502
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
